Intellia Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.2M | 241k | 17.27 |
| 2025-06-30 | $6.0M | 638k | 9.38 |
| 2025-03-31 | $3.7M | 522k | 7.11 |
| 2024-12-31 | $5.6M | 483k | 11.66 |
| 2024-09-30 | $9.5M | 460k | 20.55 |
| 2024-06-30 | $12M | 512k | 22.38 |
| 2024-03-31 | $10M | 380k | 27.51 |
| 2023-12-31 | $13M | 432k | 30.49 |
| 2023-09-30 | $13M | 407k | 31.62 |
| 2023-06-30 | $16M | 419k | 37.27 |
| 2023-03-31 | $16M | 419k | 37.27 |
| 2022-12-31 | $14M | 393k | 34.89 |
| 2022-09-30 | $23M | 403k | 55.96 |
| 2022-06-30 | $19M | 371k | 51.76 |
| 2022-03-31 | $23M | 319k | 72.67 |
| 2021-12-31 | $34M | 289k | 118.24 |
| 2021-09-30 | $39M | 289k | 134.15 |
| 2021-06-30 | $44M | 274k | 161.91 |
| 2021-03-31 | $19M | 231k | 80.26 |
| 2020-12-31 | $1.3M | 65k | 19.88 |
| 2020-09-30 | $1.3M | 65k | 19.88 |
| 2020-06-30 | $1.3M | 60k | 21.02 |
| 2020-03-31 | $597k | 49k | 12.23 |
| 2019-12-31 | $604k | 41k | 14.67 |
| 2019-09-30 | $573k | 43k | 13.35 |
| 2019-06-30 | $299k | 18k | 16.37 |
| 2018-09-30 | $247k | 8.6k | 28.62 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas